Neuromodulation News and Research

RSS

Nevro obtains new expanded MR-conditional labeling for Senza SCS system

5 Feb 2015

Loyola psychiatrist achieves Distinguished Life Fellow status in the American Psychiatric Association

Loyola University Medical Center psychiatrist Murali Rao, MD, has achieved Distinguished Life Fellow status in the American Psychiatric Association, the highest honor the profession can bestow.

4 Feb 2015

Loyola's Murali Rao achieves Distinguished Life Fellow status

Loyola University Medical Center psychiatrist Murali Rao, MD, has achieved Distinguished Life Fellow status in the American Psychiatric Association, the highest honor the profession can bestow.

4 Feb 2015

Nevro gets FDA approval letter for Senza spinal cord stimulation system

Nevro Corp., a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, today announced that it has received a letter from the U.S. Food and Drug Administration informing the company of the approvability of its Premarket Approval Application (PMA) for the Senza spinal cord stimulation (SCS) system.

23 Jan 2015

Clinatec chairman receives Lifetime Achievement Award for breakthrough research on Parkinson's disease

Prof. Alim-Louis Benabid, board chairman of Clinatec - The Edmond J. Safra Biomedical Research Center, received the Lifetime Achievement award on Dec. 13 from the North American Neuromodulation Society (NANS) for his work in developing deep brain stimulation to relieve symptoms in Parkinson’s disease patients.

16 Dec 2014

Boston Scientific Precision Spectra SCS System provides sustained relief for low back pain patients

New retrospective data evaluating the Boston Scientific Corporation Precision Spectra Spinal Cord Stimulator (SCS) System demonstrate that the device provided sustained, highly significant relief of low back pain 12 months after implantation.

14 Dec 2014

Alim Louis Benabid, Mahlon DeLong jointly win 2014 Lasker-DeBakey Clinical Medical Research Award

French neurosurgeon Alim Louis Benabid and American neurologist Mahlon DeLong were recently named winners of the 2014 Lasker-DeBakey Clinical Medical Research Award for their roles in developing deep brain stimulation (DBS) for the treatment of Parkinson disease.

2 Dec 2014

electroCore CEO highlights the importance of working with stakeholders when launching new technologies

JP Errico, founder and CEO of electroCore, speaking at The FT Global Pharmaceutical and Biotechnology Conference in London last week, emphasized the importance of working with each of the major stakeholders, i.e., patients and their advocates, key opinion-leading physicians, and decision-makers within the payor community at the earliest opportunity, particularly in regards to innovative and disruptive technology such as electroCore’s non-invasive vagus nerve stimulation (nVNS).

26 Nov 2014

Cyberonics' worldwide net sales increase 5% to $73.4M in Q2 of fiscal 2015

Cyberonics, Inc. today announced results for the quarter ended October 24, 2014.

20 Nov 2014

Pros and cons of medical marijuana to be discussed at Queensland Epilepsy Symposium

The pros and cons of medical marijuana is a discussion focus at the fifth annual Queensland Epilepsy Symposium, Epilepsy – On the Horizon.

18 Nov 2014

NeuroSigma, VA partner to evaluate eTNS system for TBI patients in Phase I clinical trial

NeuroSigma, Inc., a California-based life sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Veterans Affairs for a clinical trial to evaluate the benefits of non-invasive, external Trigeminal Nerve Stimulation (eTNS) for patients with traumatic brain injury (TBI) in a Phase I clinical trial.

15 Oct 2014

USC researchers develop new methods to advance study of human brains, epilepsy

USC biomedical engineers, neurologists and neurosurgeons develop new methods to advance the study of human brains and epilepsy. Studying the human brain is logistically complicated. Living samples of the complex and sensitive organ are limited and difficult to preserve, which means that research on them must be conducted quickly before they expire.

8 Oct 2014

Neuromod Devices receives ISO 13485 certification of Quality Management System

Neuromod Devices, the Irish medical devices company, today announced that it has successfully secured ISO 13485 certification of its Quality Management System.

19 Sep 2014

Sacral neuromodulation augments efficacy of antimuscarinics in OAB

The addition of sacral neuromodulation to antimuscarinic pharmacotherapy offers significant benefits over antimuscarinics alone in the treatment of women with idiopathic overactive bladder, study findings show.

17 Sep 2014

Vercise DBS System receives CE Mark approval for treatment of essential tremor

Boston Scientific Corporation has received CE Mark for the Vercise Deep Brain Stimulation (DBS) System for the treatment of tremor, including the most common form of this movement disorder known as essential tremor (ET).

17 Sep 2014

Researchers determine safety and effectiveness of neurostimulation to treat chronic pain

Chronic pain, which persists despite the fact that an injury has healed, can last for many months or years and may affect up to 15 percent of the adult population at any point in time.

13 Aug 2014

First peer-reviewed comprehensive expert guidance on the use of neurostimulation for pain

Reflecting groundbreaking international consensus regarding a group of rapidly evolving medical interventions for chronic pain, the International Neuromodulation Society announced it will soon publish the first peer-reviewed comprehensive expert guidance on the appropriate use of neurostimulation for pain.

12 Aug 2014

NGS issues positive coverage decision for PTNS to manage symptoms of OAB

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that National Government Services has issued a positive coverage decision for Posterior Tibial Nerve Stimulation (PTNS) for the treatment of urinary urgency, urinary frequency and urge incontinence associated with overactive bladder (OAB). Coverage for the proprietary Urgent PC device was effective August 10, 2014.

12 Aug 2014

NIH funds Phase II 90-subject pediatric clinical trial at UCLA

NeuroSigma, Inc., a California-based life sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that the U.S. National Institutes of Health (NIH) has awarded UCLA a grant that funds a Phase II 90-subject pediatric clinical trial at the University of California, Los Angeles focused on the treatment of Attention Deficit Hyperactivity Disorder (ADHD) with NeuroSigma's external trigeminal nerve stimulation (eTNS) System.

10 Jul 2014

UCLA project receives $15M to restore lost memory functions in brain-injured people

The UCLA Program in Memory Restoration has been awarded up to $15 million by the Defense Advanced Research Projects Agency (DARPA) for a four -year project aiming to help brain-injured people restore lost memory functions.

9 Jul 2014

Neuromodulation News and Research

Nevro obtains new expanded MR-conditional labeling for Senza SCS system

Loyola psychiatrist achieves Distinguished Life Fellow status in the American Psychiatric Association

Loyola's Murali Rao achieves Distinguished Life Fellow status

Nevro gets FDA approval letter for Senza spinal cord stimulation system

Clinatec chairman receives Lifetime Achievement Award for breakthrough research on Parkinson's disease

Boston Scientific Precision Spectra SCS System provides sustained relief for low back pain patients

Alim Louis Benabid, Mahlon DeLong jointly win 2014 Lasker-DeBakey Clinical Medical Research Award

electroCore CEO highlights the importance of working with stakeholders when launching new technologies

Cyberonics' worldwide net sales increase 5% to $73.4M in Q2 of fiscal 2015

Pros and cons of medical marijuana to be discussed at Queensland Epilepsy Symposium

NeuroSigma, VA partner to evaluate eTNS system for TBI patients in Phase I clinical trial

USC researchers develop new methods to advance study of human brains, epilepsy

Neuromod Devices receives ISO 13485 certification of Quality Management System

Sacral neuromodulation augments efficacy of antimuscarinics in OAB

Vercise DBS System receives CE Mark approval for treatment of essential tremor

Researchers determine safety and effectiveness of neurostimulation to treat chronic pain

First peer-reviewed comprehensive expert guidance on the use of neurostimulation for pain

NGS issues positive coverage decision for PTNS to manage symptoms of OAB

NIH funds Phase II 90-subject pediatric clinical trial at UCLA

UCLA project receives $15M to restore lost memory functions in brain-injured people

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News